16α-[18F]fluoro-17β-estradiol ([18F]FES) and 16β-[18F]fluoro-5α-dihydrotestosterone ([18F]FDHT) PET/CT allow visualization, respectively, of estrogen (ER) and androgen receptor (AR) status in tumor lesions. The gene discussed is AR; the disease is neoplasm.